Carcinoid Tumor of GI System
Showing 1 - 25 of >10,000
Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)
Completed
- Neuroendocrine Tumors
- +3 more
- Amino Acid Based Medical Food/Drink
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 2, 2022
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022
Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)
Recruiting
- Carcinoid Tumor
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 14, 2022
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)
Recruiting
- Carcinoid Syndrome
- +3 more
- Dual-Energy Computed Tomography
-
Houston, TexasM D Anderson Cancer Center
Jul 28, 2021
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Seoul (GI-102)
Recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
-
Seoul, Korea, Republic of
- +3 more
Apr 20, 2023
Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide
Withdrawn
- Neuroendocrine Tumors
- +2 more
- Telotristat ethyl
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospital and Clinics
Feb 9, 2022
Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent
Not yet recruiting
- Tricuspid Regurgitation
- +3 more
- Transcatheter Tricuspid Valved Stent Graft
-
London, England, United KingdomBarts Health NHS Trust
Apr 19, 2022
Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90
Terminated
- Neuroendocrine Tumors
- +2 more
- Lanreotide
- Y-90 microspheres
-
Denver, Colorado
- +2 more
Jul 5, 2022
Advanced Solid Tumor, Metastatic Solid Tumor, NSCLC Trial in Suwon-si, Daejeon, Seoul (GI-101, Pembrolizumab, Lenvatinib)
Recruiting
- Advanced Solid Tumor
- +7 more
- GI-101
- +3 more
-
Suwon-si, Kyeonggi-do, Korea, Republic of
- +3 more
Apr 19, 2022
Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)
Appendix Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Seattle (Acupuncture Therapy, Acupressure Therapy, Oral
Recruiting
- Appendix Carcinoma
- +12 more
- Acupuncture Therapy
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 11, 2022
Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib
Recruiting
- Atypical Carcinoid Tumor
- +18 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +425 more
Aug 12, 2022
Carcinoid Tumor Trial in Boston (Ziv-aflibercept)
Active, not recruiting
- Carcinoid Tumor
-
Boston, Massachusetts
- +2 more
Oct 14, 2022
Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)
Completed
- Carcinoid Tumor of the Small Bowel
- Neuroendocrine Tumour
- Octreotide LAR
- 177Lu-DOTA0-Tyr3-Octreotate
-
Los Angeles, California
- +38 more
Mar 10, 2022
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,
Active, not recruiting
- Carcinoid Tumor
- +2 more
- Laboratory Biomarker Analysis
- +3 more
-
Buffalo, New York
- +1 more
Nov 8, 2022
Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best
Completed
- Advanced NET of GI Origin
- +2 more
- Everolimus
- +2 more
-
La Jolla, California
- +96 more
Jul 13, 2021
Neuroendocrine Tumors - Patient Reported Outcomes
Enrolling by invitation
- Neuroendocrine Tumors
- +3 more
-
Gainesville, Florida
- +13 more
Jul 7, 2022
CNS Cancer, Head Neck Cancer, GI Cancer Trial in New York (Pencil Beam Scanning Proton Therapy)
Recruiting
- CNS Cancer
- +6 more
- Pencil Beam Scanning Proton Therapy
-
New York, New YorkThe New York Proton Center
Mar 29, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Neuroendocrine Tumor, Carcinoid Syndrome Trial in Nashville (Enterade®, Functional Assessment of Chronic Illness Therapy for
Terminated
- Neuroendocrine Tumor
- Carcinoid Syndrome
- Enterade®
- Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0)
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
May 18, 2021
Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire
Recruiting
- Locally Advanced Neuroendocrine Neoplasm
- Metastatic Neuroendocrine Neoplasm
- Placebo Administration
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Carcinoid Tumors, Pancreatic NET Trial in Tampa (Ibrutinib)
Completed
- Carcinoid Tumors
- Pancreatic NET
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020